Skip to main content
Type at least 3 characters

1,683 articles

Clinical Trial

Accepted on 02 May 2025

Phase I/II clinical trial on the safety and preliminary efficacy of donor-derived anti-leukemia cytotoxic T lymphocytes for the prevention of leukemia relapse in children given haploidentical hematopoietic stem cell transplantation: study rational and design

in Alloimmunity and Transplantation

  • Daniela Montagna
  • Patrizia Comoli
  • Matteo Tanzi
  • Enrica Montini
  • Antonia Moretta
  • Gloria Taurino
  • Stella Boghen
  • Arianna Panigari
  • Tommaso Mina
  • Giovanna Giorgiani
Frontiers in Immunology
doi 10.3389/fimmu.2025.1601961

Original Research

Published on 01 May 2025

Early cardiac events after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. subanalysis exploring cardiac toxicity conducted on behalf of GETH-TC

in Alloimmunity and Transplantation

  • Filipe R. Pinto
  • Enric Cascos
  • Estefanía Pérez-López
  • Mónica Baile-González
  • Carlos Martín Rodríguez
  • María Jesús Pascual Cascón
  • Marta Luque
  • Albert Esquirol
  • Carmen Martín Calvo
  • Felipe Peña-Muñóz
Frontiers in Immunology
doi 10.3389/fimmu.2025.1571678
  • 613 views